Enhanced Closed Incisional Negative Pressure Therapy for Treating Infectious Scars
- PMID: 40375957
- PMCID: PMC12080673
- DOI: 10.1097/GOX.0000000000006776
Enhanced Closed Incisional Negative Pressure Therapy for Treating Infectious Scars
Abstract
Background: Chronic infectious pathological scars, characterized by mutual reinforcement between infection and pathological scarring, pose challenges in reconstructive surgery. We introduce an enhanced closed incisional negative pressure therapy following a 1-stage surgery to simultaneously eradicate infection and alleviate wound tension.
Methods: A total of 25 patients who underwent chronic infectious pathological scar treatment by using this enhanced closed incisional negative pressure therapy were retrospectively reviewed. The outcomes were evaluated by postoperative recurrence frequency of infection and scarring during a 1-year follow-up, as well as the Patient and Observer Scar Assessment Scale and quality-of-life scores.
Results: After treatment, no serious complications, such as incision dehiscence, occurred. The average wound healing time was 12.68 days. Only 1 patient experienced surgical site scarring. Besides, average infection frequency decreased significantly from 6.40 to 0.00 times per year (P < 0.0001). The Patient and Observer Scar Assessment Scale score decreased from 81.60 to 25.36 (P < 0.0001), whereas the quality-of-life score increased from 2.20 to 4.88 (P < 0.0001).
Conclusions: The enhanced closed incisional negative pressure therapy effectively facilitated infectious wound healing in a 1-stage operation and simultaneously prevented infection and scarring recurrence in long-term follow-up, resulting in satisfactory postoperative outcomes.
Copyright © 2025 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Conflict of interest statement
The authors have no financial interest to declare in relation to the content of this article. This study was supported by grants from the National Natural Science Foundation of China (82372535), the Shanghai Clinical Research Center of Plastic and Reconstructive Surgery supported by the Science and Technology Commission of Shanghai Municipality (22MC1940300), and the Shanghai Municipal Key Clinical Specialty (shslczdzk00901).
Figures
References
-
- Elsaie ML. Update on management of keloid and hypertrophic scars: a systemic review. J Cosmet Dermatol. 2021;20:2729–2738. - PubMed
-
- Huang C, Wu Z, Du Y, Ogawa R. The epidemiology of keloids. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, eds. Textbook on Scar Management: State of the Art Management and Emerging Technologies. Springer; 2020;Chapter 4. - PubMed
LinkOut - more resources
Full Text Sources